β-parvin, a cytoskeletal protein, plays a crucial role in cell adhesion, migration, and signaling processes. As a component of the integrin-mediated focal adhesion complex, β-parvin acts as a scaffold protein, linking integrins to the actin cytoskeleton and various signaling molecules. This linkage is essential for transmitting mechanical signals from the extracellular matrix to the intracellular environment, regulating cell shape, motility, and differentiation. Moreover, β-parvin interacts with several cytoskeletal and signaling proteins, including paxillin, focal adhesion kinase (FAK), and ILK, thereby contributing to the dynamic regulation of focal adhesion turnover and cell adhesion dynamics.
The activation of β-parvin is tightly regulated by various mechanisms. One crucial mechanism involves its phosphorylation status, where phosphorylation at specific residues modulates its interaction with binding partners and its subcellular localization. For instance, phosphorylation by FAK and ILK enhances β-parvin's association with the focal adhesion complex, promoting its stability and function. Additionally, post-translational modifications such as ubiquitination and sumoylation have been implicated in regulating β-parvin activity and turnover. Furthermore, the availability of binding partners and the structural conformation of β-parvin also influence its activation state. For instance, the binding of integrins to extracellular matrix components triggers conformational changes in β-parvin, facilitating its interaction with other focal adhesion proteins and downstream signaling effectors. Overall, the activation of β-parvin is a tightly regulated process involving multiple signaling pathways and post-translational modifications, ensuring its precise control over cell adhesion and migration processes.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | ¥1162.00 ¥2674.00 | 36 | |
双吲哚马来酰亚胺 I(GF 109203X)是一种 PKC 抑制剂,可通过调节 PKC 途径间接增强 β-parvin 的活性,而 β-parvin 在肌动蛋白细胞骨架重组中发挥着重要作用。 | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | ¥2053.00 ¥7818.00 | 88 | |
Y-27632是一种游离碱,是一种ROCK抑制剂,通过影响RhoA/ROCK途径间接激活β-parvin,该途径会影响β-parvin参与其中的肌动蛋白动力学和粘着斑组装。 | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | ¥857.00 ¥1692.00 ¥8179.00 ¥15626.00 ¥23128.00 | 73 | |
福斯可林(一种腺苷酸环化酶激活剂)通过增加cAMP水平间接增强β-parvin的活性,从而调节细胞骨架组织和细胞粘附动态,发挥β-parvin的作用。 | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | ¥1004.00 ¥2956.00 | 13 | |
ML-7盐酸盐是一种肌球蛋白轻链激酶抑制剂,可通过改变肌动蛋白-肌球蛋白收缩力间接激活β-parvin,从而影响β-parvin活跃的细胞骨架重组。 | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | ¥1061.00 ¥3937.00 | 114 | |
Thapsigargin是一种SERCA泵抑制剂,通过改变钙信号间接增强β-parvin活性,从而影响肌动蛋白细胞骨架动力学和细胞粘附,这是β-parvin发挥功能的关键领域。 | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | ¥801.00 ¥2933.00 ¥5472.00 ¥10707.00 | ||
Blebbistatin 是一种肌球蛋白 II 抑制剂,它通过调节肌动蛋白收缩力间接激活了 β-parvin,影响了细胞骨架组织和涉及 β-parvin 的病灶粘附过程。 | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | ¥2031.00 ¥3373.00 | 59 | |
Jasplakinolide 是一种肌动蛋白稳定剂,它通过稳定肌动蛋白丝间接激活 β-parvin,从而影响细胞骨架结构和涉及 β-parvin 的病灶粘附组装。 | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | ¥338.00 ¥1015.00 | 8 | |
CCG-1423是一种RhoA转录抑制因子,它通过影响RhoA介导的信号通路间接激活β-parvin,而RhoA在β-parvin参与的肌动蛋白动力学和病灶粘附中发挥作用。 | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | ¥1365.00 ¥4423.00 | 148 | |
PI3K 抑制剂 LY 294002 可通过改变 PI3K/Akt 信号间接激活 β-parvin,而 PI3K/Akt 信号与涉及 β-parvin 的肌动蛋白细胞骨架重排和病灶粘附动力学有关。 |